Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial.
semaglutide 對於 2 型糖尿病患者糖尿病腎病初級預防的影響:SUSTAIN 6 隨機對照試驗的事後分析。
Diabetes Obes Metab 2024-08-27
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.
SUSTAIN 6和PIONEER 6試驗的事後分析表明,高心血管風險的2型糖尿病患者接受semaglutide治療,腎功能比安慰劑更穩定。
Kidney Int 2023-08-30
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Semaglutide對基線腎功能參數不同的2型糖尿病患者及高心血管疾病風險者主要不良心血管事件的影響:SUSTAIN 6和PIONEER 6事後合併分析。
Cardiovasc Diabetol 2023-11-21
Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.
慢性腎臟疾病及其嚴重程度對賽馬魯替胰噴酮在第2型糖尿病患者療效的影響:多中心實務研究。
Front Endocrinol (Lausanne) 2023-11-22
Effects of Oral Semaglutide on Renal Function in Diabetic Kidney Disease: A Short-term Clinical Study.
口服 Semaglutide 對糖尿病腎病的腎功能影響:短期臨床研究。
In Vivo 2024-01-04
The impact of weekly semaglutide, a glucagon-like peptide-1 agonist, on kidney outcomes in adults with type 2 diabetes mellitus.
每週一次的血糖素樣肽-1激動劑semaglutide對2型糖尿病成人腎臟結果的影響。
J Family Med Prim Care 2024-04-25
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6.
Semaglutide對SUSTAIN 6和PIONEER 6中不同基線HbA1c、血壓、體重和白蛋白尿水平的腎功能影響。
Nephrol Dial Transplant 2024-07-02
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial.
SUSTAIN 6 試驗中,按 KDIGO 風險類別劑量每週一次的 Semaglutide 對腎病結果的影響。
Kidney Int Rep 2024-07-31